journal article·2025-03Open access

The Diminution of R‐Loops Generated by LncRNA DSP‐AS1 Inhibits DSP Gene Transcription to Impede the Re‐Epithelialization During Diabetic Wound Healing

Chen Yang, Hong Lian, Hengli Luo, Chenlin Song, Jianghong Lin, Zhuoxian Liang, Yulin Yang, Xiaosi Hong, Shaohua Li, Yanbo Chen, Liangyan Wu, Li Yan, Sifan Chen, Meng Ren

Advanced Science· Volume 12· Issue 12

Abstract

Abstract Re‐epithelialization constitutes a critical stage in the intricate process of wound healing, yet its mechanisms in the context of diabetic wounds remain elusive. In this study, the role of the mesenchymal‐epithelial transition (MET) vis‐à‐vis the epithelial‐mesenchymal transition (EMT) of keratinocytes in diabetic wound re‐epithelialization is investigated. The findings reveal an impediment in the MET process, rather than EMT, which significantly compromised re‐epithelialization in diabetic wounds. Furthermore, Desmoplakin (DSP) gene expression, encoding a key desmosome protein, is down‐regulated in diabetic rats. This down‐regulation coincided with aberrant hypo‐demethylation of the DSP promoter. The inhibition of DSP expression is linked to reduced occupancy of Ten‐eleven translocation 3 (TET3) at the DSP promoter, consequently suppressing TET3‐dependent DNA demethylation. Additionally, a novel lncRNA termed DSP‐AS1is identified, which is antisense to DSP. Notably, DSP‐AS1 expression is down‐regulated in diabetic skin wounds, and it interacted with TET3, a DNA demethylase. Notably, DSP‐AS1 is found to form R‐loops, triple‐stranded DNA:RNA hybrids, at the DSP promoter, facilitating TET3 localization to the DSP promoter. Collectively, the findings suggest that reduced R‐loop formation by DSP‐AS1 impairs DSP gene transcription by repressing TET3‐mediated DNA demethylation. This disruption of the orchestrated re‐epithelialization process contributes to refractory diabetic wound healing.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · Wound Healing and Treatments · Diabetic Foot Ulcer Assessment and Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Endocrinology Sun Yat‐sen Memorial Hospital Sun Yat‐sen University 107 Yanjiang West Road Guangzhou 510120 China

Guang Dong Clinical Research Center for Metabolic Diseases Guangzhou 510120 China

Department of Endocrinology and Metabolism Zhuhai People's Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University) Zhuhai 519000 China

Department of Chemical and Systems Biology Stanford University Stanford CA 94305 USA

Wards of Cadres Zhuhai People's Hospital (The Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University) Zhuhai 519000 China

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Guangdong‐Hong Kong Joint Laboratory for RNA Medicine Medical Research Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 China

Nanhai Translational Innovation Center of Precision Immunology Sun Yat‐sen Memorial Hospital Foshan 528200 China

Funding

Guangdong Provincial Department of Science and Technology

References (41)

Show source-provided references
1. 10.1136/bmj.j506410.1136/bmj.j5064 ↗
2. 10.1152/physrev.00067.201710.1152/physrev.00067.2017 ↗
3. 10.1016/j.addr.2018.06.01910.1016/j.addr.2018.06.019 ↗
4. Hodorogea A. · Anal. Cell Pathol. (Amst) · 2019 · 2019
5. 10.1016/j.canlet.2017.01.02910.1016/j.canlet.2017.01.029 ↗
6. 10.1172/JCI3910410.1172/JCI39104 ↗
7. 10.1002/dvdy.2456110.1002/dvdy.24561 ↗
8. 10.1083/jcb.141.5.122910.1083/jcb.141.5.1229 ↗
9. 10.1016/j.bbamem.2007.07.01410.1016/j.bbamem.2007.07.014 ↗
10. 10.1038/nrg.2017.3310.1038/nrg.2017.33 ↗
11. 10.1016/j.jare.2023.01.00910.1016/j.jare.2023.01.009 ↗
12. 10.1016/j.molcel.2022.05.02710.1016/j.molcel.2022.05.027 ↗
13. 10.1016/j.isci.2022.10400610.1016/j.isci.2022.104006 ↗
14. 10.3390/ijms22211181610.3390/ijms222111816 ↗
15. 10.2337/db21-072410.2337/db21-0724 ↗
16. 10.1002/path.540510.1002/path.5405 ↗
17. 10.1038/ncomms1442210.1038/ncomms14422 ↗
18. 10.5808/GI.2019.17.4.e3810.5808/GI.2019.17.4.e38 ↗
19. 10.1016/j.molcel.2014.06.03110.1016/j.molcel.2014.06.031 ↗
20. 10.1101/cshperspect.a01540410.1101/cshperspect.a015404 ↗
21. 10.1021/acs.biochem.5b0114110.1021/acs.biochem.5b01141 ↗
22. 10.1038/s41588-018-0306-610.1038/s41588-018-0306-6 ↗
23. 10.1016/j.cell.2019.08.05510.1016/j.cell.2019.08.055 ↗
24. 10.1038/s41419-019-2047-610.1038/s41419-019-2047-6 ↗
25. 10.1016/j.molcel.2019.01.02410.1016/j.molcel.2019.01.024 ↗
26. 10.1101/gad.300624.11710.1101/gad.300624.117 ↗
27. 10.2337/db17-093410.2337/db17-0934 ↗
28. 10.1164/rccm.201910-1958OC10.1164/rccm.201910-1958OC ↗
29. 10.1086/49690110.1086/496901 ↗
30. 10.1111/j.1365-2133.2011.10640.x10.1111/j.1365-2133.2011.10640.x ↗
31. 10.1164/rccm.202006-2457ED10.1164/rccm.202006-2457ED ↗
32. 10.1038/s41467-021-26939-910.1038/s41467-021-26939-9 ↗
33. 10.1111/j.1365-2230.2005.01736.x10.1111/j.1365-2230.2005.01736.x ↗
34. 10.1038/s41576-019-0106-610.1038/s41576-019-0106-6 ↗
35. 10.1038/s41392-023-01537-x10.1038/s41392-023-01537-x ↗
36. 10.1146/annurev-immunol-080223-04461010.1146/annurev-immunol-080223-044610 ↗
37. 10.1038/s41556-021-00663-410.1038/s41556-021-00663-4 ↗
38. 10.1016/j.molcel.2012.01.01710.1016/j.molcel.2012.01.017 ↗
39. 10.1016/j.molcel.2017.12.03010.1016/j.molcel.2017.12.030 ↗
40. 10.2337/db17-123810.2337/db17-1238 ↗
41. 10.2337/db20-014710.2337/db20-0147 ↗